BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20687846)

  • 1. Pustulosis palmoplantaris is a disease distinct from psoriasis.
    de Waal AC; van de Kerkhof PC
    J Dermatolog Treat; 2011 Apr; 22(2):102-5. PubMed ID: 20687846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-palmoplantar lesions associated with palmoplantar pustulosis.
    Yamamoto T
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1227-32. PubMed ID: 19453807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggering role of focal infection in the induction of extra-palmoplantar lesions and pustulotic arthro-osteitis associated with palmoplantar pustulosis.
    Yamamoto T
    Adv Otorhinolaryngol; 2011; 72():89-92. PubMed ID: 21865699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options for palmoplantar pustulosis.
    Adişen E; Gürer MA
    Clin Exp Dermatol; 2010 Apr; 35(3):219-22. PubMed ID: 19874337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etanercept in the treatment of palmoplantar pustulosis.
    Bissonnette R; Poulin Y; Bolduc C; Maari C; Provost N; Syrotuik J; Poulin-Costello CM; Nigen S
    J Drugs Dermatol; 2008 Oct; 7(10):940-6. PubMed ID: 19112757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Palmoplantar pustulosis].
    Berbis P
    Rev Prat; 1991 Oct; 41(22):2165-8. PubMed ID: 1784916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pustulosis palmoplantaris and chronic eczematous hand dermatitis. Treatment, epidermal Langerhans cells and association with thyroid disease.
    Rosén K
    Acta Derm Venereol Suppl (Stockh); 1988; 137():1-52. PubMed ID: 3285630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What do we know about palmoplantar pustulosis?
    Misiak-Galazka M; Wolska H; Rudnicka L
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):38-44. PubMed ID: 27521275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis.
    Hagforsen E; Hedstrand H; Nyberg F; Michaëlsson G
    Br J Dermatol; 2010 Sep; 163(3):572-9. PubMed ID: 20426778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis.
    Yamamoto T
    Clin Drug Investig; 2019 Mar; 39(3):241-252. PubMed ID: 30632109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmoplantar pustulosis treated with itraconazole: a single, active-arm pilot study.
    V'lckova-Laskoska MT; Caca-Biljanovska NG; Laskoski DS; Kamberova SJ
    Dermatol Ther; 2009; 22(1):85-9. PubMed ID: 19222520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ; Pariser DM; Yamauchi PS
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of proelafin peptides in the sera of the patients with generalized pustular psoriasis and pustulosis palmoplantaris.
    Tanaka N; Fujioka A; Tajima S; Ishibashi A; Hirose S
    Acta Derm Venereol; 2000; 80(2):102-5. PubMed ID: 10877128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arthritis and pustulosis palmoplantaris].
    Moe AT; Jemec GB
    Ugeskr Laeger; 1996 Apr; 158(14):1984-5. PubMed ID: 8650775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism.
    Murakami M; Terui T
    J Dermatol Sci; 2020 Apr; 98(1):13-19. PubMed ID: 32201085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cutaneous non-neuronal cholinergic system and smoking related dermatoses: studies of the psoriasis variant palmoplantar pustulosis.
    Hagforsen E
    Life Sci; 2007 May; 80(24-25):2227-34. PubMed ID: 17341425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study.
    Reitamo S; Erkko P; Remitz A; Lauerma AI; Montonen O; Harjula K
    Arch Dermatol; 1993 Oct; 129(10):1273-9. PubMed ID: 8215491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin for palmoplantar pustulosis.
    Reitamo S; Erkko P; Remitz A
    J Autoimmun; 1992 Apr; 5 Suppl A():285-7. PubMed ID: 1503623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmoplantar pustulosis - a cross-sectional analysis in Germany.
    Wilsmann-Theis D; Jacobi A; Frambach Y; Philipp S; Weyergraf A; Schill T; Steinz K; Gerdes S; Mössner R
    Dermatol Online J; 2017 Apr; 23(4):. PubMed ID: 28541870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.
    Bissonnette R; Nigen S; Langley RG; Lynde CW; Tan J; Fuentes-Duculan J; Krueger JG
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1298-305. PubMed ID: 24112799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.